News

Press Releases & Articles

News & Media Coverage

Seneca Partners invests £1.2m into biotech start-up SolasCure

Seneca Partners (Seneca), the specialist SME investment business based in the North West, has invested £1.2m into biotech company, SolasCure to support the…

18 AUGUST 2021

The Biomimicry Institute's AskNature: Improved Wound Debridement Using Maggot Enzymes

Aurase® is an investigational product containing maggot enzymes that aims to help remove dead…

11 AUGUST 2021

6 Ireland-UK start-ups ready for the Catapult Semifinals

42 startups from across Europe with 6 based in Ireland-UK have been selected for the EIT Health Catapult semi-finals.

24 JUNE 2021

A Truly Revolting Treatment Is Having a Renaissance

Most people who have received maggot therapy would recommend it to others, despite the odor, pain, itching, and pure yuck factor.

2 JUNE 2021

urgo invent and care logo

Startup Solascure chosen for the URGO Mentorship Program

URGO Group announces the winner of its 2019 URGO Mentorship Program: SolasCure, a Wales-based biotech…

09 SEPTEMBER 2019

bionova logo

Will chronic wounds have a better treatment? SolasCure, a new company in Hovione Capital’s portfolio.

Today, we announce a new portfolio company: SolasCure, developing a disruptive technology

31 AUGUST 2018

brain and solascure

BRAIN Biotech AG announces the creation of SolasCure Ltd. to continue development of Aurase®

BRAIN Biotech AG is providing IP and fully integrating their development programme

22 AUGUST 2018

media coverage
press relases

BRAIN AG announces the creation of SolasCure Ltd. to continue development of Aurase®

BRAIN is providing IP and fully integrating their development programme for biological wound care based on the Aurase® enzyme…

Startup Solascure chosen for the URGO Mentorship Program

URGO Group announces the winner of its 2019 URGO Mentorship Program: SolasCure, a Wales-based biotech which has developed an innovative wound care solution…

Will chronic wounds have a better treatment? SolasCure, a new company in Hovione Capital’s portfolio.

Today, we announce a new portfolio company: SolasCure, developing a disruptive technology for wound…

media coverage
Archives
web-designer

News

News Press Releases & Articles News & Media Coverage Seneca Partners invests £1.2m into biotech start-up SolasCure Seneca Partners (Seneca), the specialist SME investment business

Read More »